Moneycontrol
Jan 13, 2017 12:28 PM IST IST | Source: Moneycontrol.com

Alembic Pharma Q3 PAT may dip 27.1% to Rs 87.3 cr: KR Choksey

Net Sales are expected to decrease by 18.4 percent Q-o-Q (down 22.1 percent Y-o-Y) to Rs 717.4 crore, according to KR Choksey.


KR Choksey has come out with its third quarter (October-December) earnings estimates for the Pharma sector. The brokerage house expects Alembic Pharma to report net profit at 87.3 crore down 27.1% quarter-on-quarter.


Net Sales are expected to decrease by 18.4 percent Q-o-Q (down 22.1 percent Y-o-Y) to Rs 717.4 crore, according to KR Choksey.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 24.8 percent Q-o-Q (down 65.2 percent Y-o-Y) to Rs 133.7 crore.

Disclaimer:
The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Sections
Follow us on
Available On